WHITEHOUSE STATION, N.J., May 20, 2007 -
Merck & Co., Inc. today announced the resignation of Peter Loescher, president, Global Human Health. Effective July 1, 2007, Mr. Loescher, 49, will take on the position of president and chief executive officer at Siemens AG.
"We thank Peter for his contributions to Merck and wish him and his family well in this new endeavor," said Richard T. Clark, chairman, president and chief executive officer. "Merck remains fully committed to the strategic initiatives and operating goals established for the Global Human Health (GHH) organization. We continue to be pleased with the strong business performance across all the GHH franchises and regions, and we are confident that it will continue."
Mr. Loescher will remain for a period of time to help with the leadership transition. Merck expects to name a new leader for the GHH organization soon.
About Merck
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.
Forward-Looking Statement
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements set forth in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2006, and in its periodic reports on Form 10-Q and Form 8-K, which the Company incorporates by reference.
|
